Fig. 2From: Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancerlocal control (a), distant progression-free survival (b) and overall survival (c)Back to article page